We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Butterwire is a professional research and portfolio analyst platform designed for high conviction low turnover active equity managers. Butterwire's AI web application was launched in June 2018 and is used by all active equity investors aiming to generate higher returns, with faster stock selection, longer investment horizons, lower portfolio risk, and less trading. The application assists active investors with their top 3 challenges: find opportunities, minimise risk, and keep aware. It is built by and for professionals but is accessible to individual investors, too. The company will utilize 10% of the proceeds to operations, 25% to development, 15% to research, 40% to business development, and 10% to administration.
pledged: 0% days to go: TBC investment: Unknown
Alvant is a British advanced materials technology group that specialises in the design, development, testing and manufacture of Aluminium Metal Matrix Composite materials and components (AMCs). These components are demanded the engineering applications across a wide range of industry sectors. Till now, they have invested £10 million for the development, prototyping & testing AMC materials with several projects secured with distinguished clients such as Ford & Safran. Alvant has seen new advances in current customer projects and applications. Space - Tesla, Design for Demise(D4D), Bauer Hockey are some examples. With the proceeds, the company will accelerate commercialisation and growth at the rate its customers are presently demanding.
pledged: nan% days to go: TBC investment: Unknown
epaysecure is a secure payment system, which offers comprehensive payment and benefit options, and allows all the services the consumer demands to be offered in one card and e-account. The prepaid business purchasing in European markets is estimated to be $700 million. The company operates in an e-banking and financial services marketing sector that helps clients by identifying new markets and bringing in new ideas to develop them through reloadable products and e-Wallet platform. The funds will be used for staffing, set up costs, other overheads including property marketing and general office costs.
pledged: 18% days to go: 42 investment: £168,340
Smart Trade App is a software-based payment app that accepts card payments directly from the phone. It helps small business owners all over the UK. The app further includes features in it such as invoicing, light CRM, team management, reporting as well as the ability to delegate jobs. Smart Trade App has got the most Disruptive Payments Tech award 2019 and has processed transaction volumes worth £1.5 million. Large high street banks in the UK have approached the company for their business accounts. They have also signed an agreement with CardOne banking and has formed a strategic partnership with MasterCard.
pledged: 25% days to go: 31 investment: £254,221
Walljam's Metrix is a live experience retail operator that offers the first football-themed social entertainment venue in partnership with the UEFA Champions League. Leveraging on Walljam's patented, interactive, mobile wall designed to gamify wall sports, Metrix is striving towards offering experience rather than products. It aims to provide a thematic and interactive space where customers are both active and entertained. Moreover, Metrix has also attracted numerous international partnerships including Real Madrid F.C, DHL and Adidas. 
pledged: nan% days to go: TBC investment: Unknown
Ablatus Therapeutics is a MedTech company developing a one-of-a-kind tissue ablation platform known as Bimodal Electric Tissue Ablation (BETA). This technology has been designed to overcome the limitations of existing products by offering ablation solutions in oncology (tumours) as well as non-oncology targets. With the proceeds, the company will finish the final elements of engineering of the generator and probe. It will also deliver formal safety test data that is a prerequisite for subsequent clinical trials.
pledged: 0% days to go: 43 investment: Unknown
Art, Analysis and Research is a leading scientific art testing company which provides art authenticity and attribution reports. The company has created a suite of state-of-the-art imaging systems, materials testing and data analytics to analyse and authenticate art. Art, Analysis and Research has offices in the two major art centres of New York and London along with market-leading mobile solution. Its customer base includes major auction houses, museums, dealers and artist foundations. The funds will be used to boost sales and marketing to meet the growing market demand.
pledged: 3% days to go: 43 investment: £39,998
Antev Limited (Antev) is a clinical-stage biopharmaceutical firm which focuses on the evolution of a drug used for prostate cancer, Teverelix TFA. The company is working on growing its copyright protection and is currently developing phase IIb clinical plans for prostate cancer. Antev is a pre-revenue company that aims at increasing its shareholder value by progressing the development of teverelix TFA towards registration whose approval is anticipated from 2023 onwards. The proceeds will be used for production, IP development, working capital and to develop a phase IIb repeat dosing clinical trial in prostate cancer.
pledged: 0% days to go: 43 investment: Unknown
Living With is a health technology company offering a pocket-friendly and simple patient management application that allows medical professionals treat and track patients remotely. The app aims to revolutionise the way doctors and hospitals access digital tools to treat patients while collecting data for medical device and pharma companies. The company owns Squeezy (a popular paid medical app in the UK) and already has five products in 17 NHS Trusts. Living With also has a contract with one of the world’s greatest medical device companies. Living With will use the proceeds to give 5 data (drug/device) and 50 access customers (clinic/doctor), become HIPAA compliant for the US and to quicken sales and marketing.
pledged: 50% days to go: 12 investment: £130,000
AgPlus has created a diagnostic platform for detecting human diseases and delivering laboratory instrument results instantly, whilst keeping in mind the business requirements and unmet requirements. The company works in collaboration with leading diagnostics companies to improve and share products quickly and globally. It aims is to become known as a leader in Point of Care diagnosis.
pledged: 57% days to go: TBC investment: £905,005
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph